REGN : Regeneron Pharmaceuticals stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2022-01-14 |
|---|---|---|---|---|
| 2022 | $945.76 | $505.71 | $1596.07 | 53.72% |
| 2023 | $1652.83 | $1622.1 | $1766.65 | 168.65% |
| 2024 | $1993.95 | $1883.29 | $2113.31 | 224.09% |
| 2025 | $1847.89 | $1259.4 | $2137.61 | 200.35% |
| 2026 | $1562.17 | $1116.25 | $2203.27 | 153.91% |
| 2027 | $1844.92 | $1762.18 | $1928.3 | 199.87% |
| 2028 | $1893.12 | $1856.41 | $1921.34 | 207.7% |
| 2029 | $1423.63 | $1099.03 | $1843.38 | 131.39% |
| 2030 | $1459.14 | $1088.06 | $2182.6 | 137.17% |
| 2031 | $1865.35 | $1733.88 | $1979.82 | 203.19% |
| 2032 | $1939.37 | $1939.37 | $1939.37 | 215.22% |
The 15 Wall Street analysts offering Regeneron Pharmaceuticals stock forecast in the last 6 months have average price target of
$745.93 with a high forecast of $850.0 and a low forecast of $571.0.
The average Regeneron Pharmaceuticals stock forecast represents a 21.24%
increase from the last price of $615.239990234375.
From AI system, total return is 3138.37% from 3070 forecasts.
For Regeneron Pharmaceuticals stock forecast for 2022, 11 predictions are offered for each month of 2022 with average Regeneron Pharmaceuticals stock
forecast of $945.76, a high forecast of $1596.07, and a low forecast of $505.71.
The average Regeneron Pharmaceuticals stock forecast 2022 represents a 53.72%
increase from the last price of $615.239990234375.
For Regeneron Pharmaceuticals stock forecast for 2023, 12 predictions are offered for each month of 2023 with average Regeneron Pharmaceuticals stock
forecast of $1652.83, a high forecast of $1766.65, and a low forecast of $1622.1.
The average Regeneron Pharmaceuticals stock forecast 2023 represents a 168.65%
increase from the last price of $615.239990234375.
For Regeneron Pharmaceuticals stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Regeneron Pharmaceuticals stock
forecast of $1847.89, a high forecast of $2137.61, and a low forecast of $1259.4.
The average Regeneron Pharmaceuticals stock forecast 2025 represents a 200.35%
increase from the last price of $615.239990234375.
For Regeneron Pharmaceuticals stock forecast for 2027 (5 year), 12 predictions are offered for each month of 2027 with average Regeneron Pharmaceuticals stock
forecast of $1844.92, a high forecast of $1928.3, and a low forecast of $1762.18.
The average Regeneron Pharmaceuticals stock forecast 2027 represents a 199.87%
increase from the last price of $615.239990234375.
For Regeneron Pharmaceuticals stock forecast for 2030, 12 predictions are offered for each month of 2030 with average Regeneron Pharmaceuticals stock
forecast of $1459.14, a high forecast of $2182.6, and a low forecast of $1088.06.
The average Regeneron Pharmaceuticals stock forecast 2030 represents a 137.17%
increase from the last price of $615.239990234375.
For Regeneron Pharmaceuticals stock forecast for 2032 (10 year), 1 predictions are offered for each month of 2032 with average Regeneron Pharmaceuticals stock
forecast of $1939.37, a high forecast of $1939.37, and a low forecast of $1939.37.
The average Regeneron Pharmaceuticals stock forecast 2032 represents a 215.22%
increase from the last price of $615.239990234375.
Please, see more forecasts below.
REGN : Regeneron Pharmaceuticals stock forecast by Wall Street Analysts
The average Regeneron Pharmaceuticals stock forecast from last 6 month is $745.93, and this show a 4.54% increase in average from the prior price target of the each prediction. Also, this average forecast of $745.93 represents a 19.29% increase from the past average forecast of $625.31, 6 months ago from 16 wall street analysts.
Regeneron Pharmaceuticals stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2022-01-17 | $641.77 | 4.31% |
| 2022-01-18 | $636.64 | -0.80% |
| 2022-01-19 | $638.95 | 0.36% |
| 2022-01-20 | $653.19 | 2.23% |
| 2022-01-21 | $664.51 | 1.73% |
REGN : Long term Regeneron Pharmaceuticals stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2022 Feb. is $567.25 , for 2023 Jan. is $1622.10 , for 2026 Jan. is $1163.64 , for 2027 Jan. is $1844.05 , for 2031 Jan. is $1951.39 , and for 2032 Jan. is $1939.37.
REGN : Regeneron Pharmaceuticals stock forecast for 2022
| Date | Price Target | Change |
|---|---|---|
| 2022 Feb. | $567.25 | -7.80% |
| 2022 Mar. | $521.69 | -8.03% |
| 2022 Apr. | $505.71 | -3.06% |
| 2022 May. | $547.83 | 8.33% |
| 2022 Jun. | $653.95 | 19.37% |
| 2022 Jul. | $803.31 | 22.84% |
| 2022 Aug. | $972.47 | 21.06% |
| 2022 Sep. | $1277.79 | 31.40% |
| 2022 Oct. | $1425.88 | 11.59% |
| 2022 Nov. | $1531.39 | 7.40% |
| 2022 Dec. | $1596.07 | 4.22% |
REGN : Regeneron Pharmaceuticals stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Jan. | $1622.10 | 1.63% |
| 2023 Feb. | $1630.52 | 0.52% |
| 2023 Mar. | $1633.91 | 0.21% |
| 2023 Apr. | $1635.80 | 0.12% |
| 2023 May. | $1638.08 | 0.14% |
| 2023 Jun. | $1639.21 | 0.07% |
| 2023 Jul. | $1640.37 | 0.07% |
| 2023 Aug. | $1642.65 | 0.14% |
| 2023 Sep. | $1646.65 | 0.24% |
| 2023 Oct. | $1657.81 | 0.68% |
| 2023 Nov. | $1680.22 | 1.35% |
| 2023 Dec. | $1766.65 | 5.14% |
REGN : Regeneron Pharmaceuticals stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $1883.29 | 6.60% |
| 2024 Feb. | $1907.07 | 1.26% |
| 2024 Mar. | $1886.32 | -1.09% |
| 2024 Apr. | $1885.68 | -0.03% |
| 2024 May. | $1918.32 | 1.73% |
| 2024 Jun. | $1992.28 | 3.86% |
| 2024 Jul. | $2095.46 | 5.18% |
| 2024 Aug. | $2113.31 | 0.85% |
| 2024 Sep. | $2034.63 | -3.72% |
| 2024 Oct. | $2041.36 | 0.33% |
| 2024 Nov. | $2074.73 | 1.63% |
| 2024 Dec. | $2094.98 | 0.98% |
REGN : Regeneron Pharmaceuticals stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $2117.67 | 1.08% |
| 2025 Feb. | $2134.45 | 0.79% |
| 2025 Mar. | $2137.61 | 0.15% |
| 2025 Apr. | $2136.59 | -0.05% |
| 2025 May. | $2105.27 | -1.47% |
| 2025 Jun. | $2030.76 | -3.54% |
| 2025 Jul. | $1904.46 | -6.22% |
| 2025 Aug. | $1762.06 | -7.48% |
| 2025 Sep. | $1663.44 | -5.60% |
| 2025 Oct. | $1528.62 | -8.11% |
| 2025 Nov. | $1394.36 | -8.78% |
| 2025 Dec. | $1259.40 | -9.68% |
REGN : Regeneron Pharmaceuticals stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $1163.64 | -7.60% |
| 2026 Feb. | $1126.27 | -3.21% |
| 2026 Mar. | $1116.25 | -0.89% |
| 2026 Apr. | $1119.08 | 0.25% |
| 2026 May. | $1143.65 | 2.20% |
| 2026 Jun. | $1529.22 | 33.71% |
| 2026 Jul. | $1719.62 | 12.45% |
| 2026 Aug. | $1553.74 | -9.65% |
| 2026 Sep. | $2203.27 | 41.80% |
| 2026 Oct. | $2073.46 | -5.89% |
| 2026 Nov. | $2067.82 | -0.27% |
| 2026 Dec. | $1930.06 | -6.66% |
REGN : Regeneron Pharmaceuticals stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $1844.05 | -4.46% |
| 2027 Feb. | $1762.18 | -4.44% |
| 2027 Mar. | $1884.10 | 6.92% |
| 2027 Apr. | $1899.70 | 0.83% |
| 2027 May. | $1871.89 | -1.46% |
| 2027 Jun. | $1824.40 | -2.54% |
| 2027 Jul. | $1783.43 | -2.25% |
| 2027 Aug. | $1763.25 | -1.13% |
| 2027 Sep. | $1791.19 | 1.58% |
| 2027 Oct. | $1871.85 | 4.50% |
| 2027 Nov. | $1928.30 | 3.02% |
| 2027 Dec. | $1914.75 | -0.70% |
REGN : Regeneron Pharmaceuticals stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $1872.47 | -2.21% |
| 2028 Feb. | $1867.46 | -0.27% |
| 2028 Mar. | $1886.39 | 1.01% |
| 2028 Apr. | $1900.43 | 0.74% |
| 2028 May. | $1904.35 | 0.21% |
| 2028 Jun. | $1902.86 | -0.08% |
| 2028 Jul. | $1905.72 | 0.15% |
| 2028 Aug. | $1921.34 | 0.82% |
| 2028 Sep. | $1917.52 | -0.20% |
| 2028 Oct. | $1900.85 | -0.87% |
| 2028 Nov. | $1881.60 | -1.01% |
| 2028 Dec. | $1856.41 | -1.34% |
REGN : Regeneron Pharmaceuticals stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $1843.38 | -0.70% |
| 2029 Feb. | $1833.70 | -0.53% |
| 2029 Mar. | $1700.33 | -7.27% |
| 2029 Apr. | $1595.00 | -6.19% |
| 2029 May. | $1518.35 | -4.81% |
| 2029 Jun. | $1431.24 | -5.74% |
| 2029 Jul. | $1342.48 | -6.20% |
| 2029 Aug. | $1262.09 | -5.99% |
| 2029 Sep. | $1195.24 | -5.30% |
| 2029 Oct. | $1146.73 | -4.06% |
| 2029 Nov. | $1115.97 | -2.68% |
| 2029 Dec. | $1099.03 | -1.52% |
REGN : Regeneron Pharmaceuticals stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $1091.12 | -0.72% |
| 2030 Feb. | $1088.06 | -0.28% |
| 2030 Mar. | $1092.54 | 0.41% |
| 2030 Apr. | $1107.57 | 1.38% |
| 2030 May. | $1109.31 | 0.16% |
| 2030 Jun. | $1124.73 | 1.39% |
| 2030 Jul. | $1181.86 | 5.08% |
| 2030 Aug. | $1317.17 | 11.45% |
| 2030 Sep. | $2145.04 | 62.85% |
| 2030 Oct. | $2182.60 | 1.75% |
| 2030 Nov. | $2059.68 | -5.63% |
| 2030 Dec. | $2009.96 | -2.41% |
REGN : Regeneron Pharmaceuticals stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $1951.39 | -2.91% |
| 2031 Feb. | $1922.59 | -1.48% |
| 2031 Mar. | $1902.20 | -1.06% |
| 2031 Apr. | $1890.34 | -0.62% |
| 2031 May. | $1882.89 | -0.39% |
| 2031 Jun. | $1869.14 | -0.73% |
| 2031 Jul. | $1791.98 | -4.13% |
| 2031 Aug. | $1737.59 | -3.03% |
| 2031 Sep. | $1733.88 | -0.21% |
| 2031 Oct. | $1791.93 | 3.35% |
| 2031 Nov. | $1930.44 | 7.73% |
| 2031 Dec. | $1979.82 | 2.56% |
REGN : Regeneron Pharmaceuticals stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $1939.37 | -2.04% |
Financial Data for Regeneron Pharmaceuticals stock
Frequently Asked Questions about Regeneron Pharmaceuticals stock forecast
Is Regeneron Pharmaceuticals a good long term stock?
From Regeneron Pharmaceuticals stock forecast , Regeneron Pharmaceuticals (REGN) stock cannot be a good investment choice. According to AI Pickup, the Regeneron Pharmaceuticals stock price forecast for 2022 Feb. is $567.252531291371 From Regeneron Pharmaceuticals stock forecast , Regeneron Pharmaceuticals (REGN) stock can be a good investment choice. According to AI Pickup, the Regeneron Pharmaceuticals stock price forecast for 2023 Jan. is $1622.10224873283 From Regeneron Pharmaceuticals stock forecast , Regeneron Pharmaceuticals (REGN) stock can be a good investment choice. According to AI Pickup, the Regeneron Pharmaceuticals stock price forecast for 2026 Jan. is $1163.63835019261 From Regeneron Pharmaceuticals stock forecast , Regeneron Pharmaceuticals (REGN) stock can be a good investment choice. According to AI Pickup, the Regeneron Pharmaceuticals stock price forecast for 2027 Jan. is $1844.0474542908 From Regeneron Pharmaceuticals stock forecast , Regeneron Pharmaceuticals (REGN) stock can be a good investment choice. According to AI Pickup, the Regeneron Pharmaceuticals stock price forecast for 2031 Jan. is $1951.39261801503 From Regeneron Pharmaceuticals stock forecast , Regeneron Pharmaceuticals (REGN) stock can be a good investment choice. According to AI Pickup, the Regeneron Pharmaceuticals stock price forecast for 2032 Jan. is $1939.3709451591
Is Regeneron Pharmaceuticals stock overvalued?
Regeneron Pharmaceuticals (REGN) stock is expected to go UP . Therefore, AI Pickup would say that Regeneron Pharmaceuticals (REGN) stock is NOT overvalued.
Will Regeneron Pharmaceuticals stock price go up?
Yes. The Regeneron Pharmaceuticals stock price forecast for 2023 Jan. is $1622.10224873283
Is Regeneron Pharmaceuticals stock a good buy now?
Since closing price on 2022-01-14 is $615.239990234375 and forecast for 2023 Jan. is $1622.10, Regeneron Pharmaceuticals stock is a good 1 year investment.